{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:54:23Z","timestamp":1781506463340,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer US","isbn-type":[{"value":"9781071648100","type":"print"},{"value":"9781071648117","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4811-7_4","type":"book-chapter","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:09:39Z","timestamp":1759277379000},"page":"47-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Manual Immunofluorescence Staining for Dystrophin and Key Dystrophin-Associated Proteins"],"prefix":"10.1007","author":[{"given":"Hui","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah J.","family":"Prom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Beatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1083\/jcb.115.6.1685","volume":"115","author":"K Ohlendieck","year":"1991","unstructured":"Ohlendieck K, Campbell KP (1991) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115:1685\u20131694","journal-title":"J Cell Biol"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev-pathmechdis-012418-012945","volume":"14","author":"N Shahnoor","year":"2019","unstructured":"Shahnoor N, Siebers EM, Brown KJ et al (2019) Pathological issues in dystrophinopathy in the age of genetic therapies. Annu Rev Pathol 14:105\u2013126","journal-title":"Annu Rev Pathol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1055\/s-2008-1071434","volume":"22","author":"T Voit","year":"1991","unstructured":"Voit T, Stuettgen P, Cremer M et al (1991) Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot. Neuropediatrics 22:152\u2013162","journal-title":"Neuropediatrics"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-1-0716-2772-3_16","volume":"2587","author":"CH Hakim","year":"2023","unstructured":"Hakim CH, Burke MJ, Teixeira J et al (2023) Histological assessment of gene therapy in the canine DMD model. Methods Mol Biol 2587:303\u2013338","journal-title":"Methods Mol Biol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-030-03095-7_12","volume-title":"Muscle gene therapy","author":"MWS Lawlor","year":"2019","unstructured":"Lawlor MWS, Childers MK, Brown KJ (2019) Histological and biochemical evaluation of muscle gene therapy. In: Duan DMJR (ed) Muscle gene therapy, 2nd edn. Springer, pp 207\u2013226","edition":"2"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell JR, Sahenk Z, Lehman K et al (2020) Assessment of systemic delivery of rAAVrh74.MHCK7. Micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol 77:1122\u20131131","journal-title":"JAMA Neurol"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0006-291X(02)00362-5","volume":"293","author":"M Sakamoto","year":"2002","unstructured":"Sakamoto M, Yuasa K, Yoshimura M et al (2002) Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 293:1265\u20131272","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/mt.2012.283","volume":"21","author":"JH Shin","year":"2013","unstructured":"Shin JH, Pan X, Hakim CH et al (2013) Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy. Mol Ther 21:750\u2013757","journal-title":"Mol Ther"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/10611860400029002","volume":"13","author":"RH Weisbart","year":"2005","unstructured":"Weisbart RH, Hansen JE, Nishimura RN et al (2005) An intracellular delivery vehicle for protein transduction of micro-dystrophin. J Drug Target 13:81\u201387","journal-title":"J Drug Target"},{"key":"4_CR10","first-page":"302","volume-title":"Muscle biopsy: a practical approach","author":"VDSCA Dubowitz","year":"2013","unstructured":"Dubowitz VDSCA (2013) Muscular dystrophies and allied disorders III: congenital muscular dystrophies and associated disorders. In: Muscle biopsy: a practical approach, 3rd edn. Elsevier, pp 302\u2013330","edition":"3"},{"key":"4_CR11","doi-asserted-by":"crossref","unstructured":"Meng H, Janssen PM, Grange RW et al (2014) Tissue triage and freezing for models of skeletal muscle disease. J Vis Exp","DOI":"10.3791\/51586-v"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nmd.2022.12.007","volume":"33","author":"JF Boehler","year":"2023","unstructured":"Boehler JF, Brown KJ, Beatka M et al (2023) Clinical potential of microdystrophin as a surrogate endpoint. Neuromuscul Disord 33:40\u201349","journal-title":"Neuromuscul Disord"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"eabo1815","DOI":"10.1126\/scitranslmed.abo1815","volume":"15","author":"SM Birch","year":"2023","unstructured":"Birch SM, Lawlor MW, Conlon TJ et al (2023) Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci Transl Med 15:eabo1815","journal-title":"Sci Transl Med"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.omtm.2021.02.024","volume":"21","author":"SE Hamm","year":"2021","unstructured":"Hamm SE, Fathalikhani DD, Bukovec KE et al (2021) Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. Mol Ther Methods Clin Dev 21:144\u2013160","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1166206","DOI":"10.3389\/fphys.2023.1166206","volume":"14","author":"SE Hamm","year":"2023","unstructured":"Hamm SE, Yuan C, McQueen LF et al (2023) Prolonged voluntary wheel running reveals unique adaptations in mdx mice treated with microdystrophin constructs +\/\u2212 the nNOS-binding site. Front Physiol 14:1166206","journal-title":"Front Physiol"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12883-018-1207-0","volume":"18","author":"B Balci-Hayta","year":"2018","unstructured":"Balci-Hayta B, Talim B, Kale G et al (2018) LARGE expression in different types of muscular dystrophies other than dystroglycanopathy. BMC Neurol 18:207","journal-title":"BMC Neurol"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1750-3639.2008.00198.x","volume":"19","author":"C Jimenez-Mallebrera","year":"2009","unstructured":"Jimenez-Mallebrera C, Torelli S, Feng L et al (2009) A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol 19:596\u2013611","journal-title":"Brain Pathol"}],"container-title":["Methods in Molecular Biology","Duchenne Muscular Dystrophy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4811-7_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:32:56Z","timestamp":1781505176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4811-7_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"ISBN":["9781071648100","9781071648117"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4811-7_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}